Search results for "Treatment outcome"

showing 5 items of 3755 documents

Evaluation of Surgical Outcomes of Abdominal Radical Hysterectomy and Total Laparoscopic Radical Hysterectomy for Cervical Cancer: A Retrospective An…

2022

Although a surgical approach is one of the key treatments for stages IA1-IIA2, results of the Laparoscopic Approach to Cervical Cancer (LACC) published in 2018 radically changed the field, since minimally invasive surgery was associated with a four-fold higher rate of recurrence and a six-fold higher rate of all-cause death compared to an open approach. We aimed to evaluate surgical outcomes of abdominal radical hysterectomy (ARH) and total laparoscopic radical hysterectomy (TLRH) for cervical cancer, including data collected before the LACC trial. In our retrospective analysis, operative time was significantly longer in TLRH compared to ARH (p < 0.0001), although this disadvantage could…

total laparoscopic radical hysterectomycervical cancerHealth Toxicology and Mutagenesiscervical cancer; abdominal radical hysterectomy; total laparoscopic radical hysterectomy; minimally invasive surgery; surgical outcomesPublic Health Environmental and Occupational HealthUterine Cervical NeoplasmsHysterectomysurgical outcomesSettore MED/40 - Ginecologia E OstetriciaTreatment Outcomeabdominal radical hysterectomyHumansLaparoscopyFemaleabdominal radical hysterectomy; cervical cancer; minimally invasive surgery; surgical outcomes; total laparoscopic radical hysterectomy; Female; Humans; Retrospective Studies; Neoplasm Staging; Hysterectomy; Treatment Outcome; Uterine Cervical Neoplasms; Laparoscopyminimally invasive surgeryNeoplasm StagingRetrospective StudiesInternational Journal of Environmental Research and Public Health; Volume 19; Issue 20; Pages: 13176
researchProduct

Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial

2022

Background and purpose: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with limited treatment options. RNS60 is an immunomodulatory and neuroprotective investigational product that has shown efficacy in animal models of ALS and other neurodegenerative diseases. Its administration has been safe and well tolerated in ALS subjects in previous early phase trials. Methods: This was a phase II, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial. Participants diagnosed with definite, probable or probable laboratory-supported ALS were assigned to receive RNS60 or placebo administered for 24 weeks intravenously (375 ml) once a week and via nebul…

treatmentAmyotrophic Lateral Sclerosisplacebo-controlledNeurodegenerative DiseasesALS; clinical trial; placebo-controlled; randomized; treatmentclinical trialTreatment OutcomeNeurologyDouble-Blind MethodrandomizedQuality of LifeHumansSettore MED/26 - NeurologiaNeurology (clinical)ALSBiomarkers
researchProduct

Noninvasive neurostimulation methods for migraine therapy: The available evidence.

2016

Background Migraine is one of the most disabling neurological disorders. The current pharmacological armamentarium is not satisfying for a large proportion of patients because the responder rate does not exceed 50% on average and the most effective drugs often induce intolerable side effects. During recent years, noninvasive central and peripheral neuromodulation methods have been explored for migraine treatment. Overview A review of the available evidence suggests that noninvasive neuromodulation techniques could be beneficial for migraine patients. The transcranial stimulation methods allow modulating selectively cortical activity and can thus be curtailed to the patient’s pathophysiologi…

vagus nervesneurology (clinical)orbital stimulationmedicine.medical_specialtymedicine.medical_treatmentMigraine DisordersTranscranial Direct Current Stimulation03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationmedicineHumans030212 general & internal medicineMigraine treatmentDeep transcranial magnetic stimulationNeurostimulationtranscranial direct current stimulation; transcranial magnetic stimulation; transcutaneous suprave stimulation; evidence-based medicine; humans; migraine disorders; transcranial direct current stimulation; transcranial magnetic stimulation; transcutaneous electric nerve stimulation; treatment outcome; neurology (clinical)orbital stimulation; vagus nervesEvidence-Based MedicineTranscranial direct-current stimulationbusiness.industryGeneral Medicinemedicine.diseaseTranscranial Magnetic StimulationNeuromodulation (medicine)Transcranial magnetic stimulationTreatment OutcomeMigraineAnesthesiaTranscutaneous Electric Nerve StimulationNeurology (clinical)business030217 neurology & neurosurgeryVagus nerve stimulationtranscutaneous suprave stimulationCephalalgia : an international journal of headache
researchProduct

Vascularized lymph node transfer for treatment of extremity lymphedema: An overview of current controversies regarding donor sites, recipient sites a…

2018

As lymphatic microsurgery has become more common, vascularized lymph node transfer ascended to the forefront in many centers for the surgical management of advanced stages of lymphedema showing substantial clinical improvement. However, no consensus has been reached among experts regarding many details of the procedures, including patient selection criteria, type of treatment, donor, and recipient sites and postoperative evaluation of the outcome. Here, we will review these issues and provide the current results of this procedure.

vascularized lymph node transfer lymphedema lymphatic microsurgerymedicine.medical_specialtymedicine.medical_treatmentTreatment outcome030230 surgery03 medical and health sciences0302 clinical medicinemedicineHumansLymphedemaLymph nodebusiness.industryGeneral surgeryAdvanced stageExtremitiesGeneral MedicineMicrosurgerymedicine.diseaselymphatic microsurgery; lymphedema; vascularized lymph node transfer; Humans; Lymph Nodes; Lymphedema; Treatment Outcome; ExtremitiesLymphatic systemLymphedemamedicine.anatomical_structureTreatment OutcomeOncology030220 oncology & carcinogenesisSurgeryLymph NodesbusinessJournal of surgical oncology
researchProduct

Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled…

2013

Obesity is an unfavorable prognostic factor in breast cancer (BC) patients regardless of menopausal status and treatment received. However, the association between obesity and survival outcome by pathological subtype requires further clarification. METHODS: We performed a retrospective analysis including 5,683 operable BC patients enrolled in four randomized clinical trials (GEICAM/9906, GEICAM/9805, GEICAM/2003-02, and BCIRG 001) evaluating anthracyclines and taxanes as adjuvant treatments. Our primary aim was to assess the prognostic effect of body mass index (BMI) on disease recurrence, breast cancer mortality (BCM), and overall mortality (OM). A secondary aim was to detect differences o…

Índice de Masa CorporalOncologyReceptor ErbB-2medicine.medical_treatmentObesidad:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Survival Analysis [Medical Subject Headings]Supervivencia sin EnfermedadBody Mass IndexAntineoplastic Combined Chemotherapy ProtocolsMedicineAnthracyclinesYoung adultMedicine(all)Hazard ratioNeoplasias de la MamaPronósticoFemeninoMiddle AgedPrognosisChemotherapy regimenTreatment OutcomeFemaleTaxoidsMastectomyResearch ArticleAdultmedicine.medical_specialtyAnálisis de Supervivencia:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Physical Examination::Body Constitution::Body Weights and Measures::Body Mass Index [Medical Subject Headings]Breast NeoplasmsDisease-Free SurvivalYoung AdultBreast cancerInternal medicineAdjuvant therapyHumansObesity:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Disease-Free Survival [Medical Subject Headings]:Diseases::Neoplasms::Neoplasms by Site::Breast Neoplasms [Medical Subject Headings]AgedGynecologyDose-Response Relationship Drugbusiness.industry:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents [Medical Subject Headings]Retrospective cohort studyAntineoplásicosmedicine.disease:Diseases::Nutritional and Metabolic Diseases::Nutrition Disorders::Overnutrition::Obesity [Medical Subject Headings]:Check Tags::Female [Medical Subject Headings]Multivariate Analysis:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis [Medical Subject Headings]Neoplasm Recurrence LocalbusinessBody mass index
researchProduct